Industry / Healthcare

GTM for Healthcare Tech Companies

Healthcare tech has the longest buying cycles in B2B, the most complex stakeholder committees, and the most evidence-driven buyers. We build outbound, SEO, and demand generation systems for health tech vendors selling to hospitals, health systems, and payers — designed for 12 to 18 month cycles and the reality of EHR integration and clinical validation.

The shape of healthcare tech GTM in 2026

Healthcare technology is the single most committee-driven category in B2B software. A typical hospital or health system purchase involves a CMIO or CNIO evaluating clinical fit, a CIO or CTO evaluating IT and EHR integration, a VP Clinical Operations evaluating workflow impact, a CFO or VP Revenue Cycle evaluating financial return, one or more physician champions lobbying internally, a compliance and privacy officer reviewing HIPAA and BAA terms, and a procurement team negotiating commercial terms. It is not unusual for 10 to 15 stakeholders to touch a single decision. Every one of them can delay or kill the deal, and none of them can approve it alone.

Buying cycles are long because healthcare capital planning is annual and locked. Most health systems set their software investment priorities during an annual capital planning process in the second or third quarter for the following fiscal year. If your deal is not on the list, you are not buying this year — you are selling the relationship that gets you on next year's list. GTM strategies that ignore this calendar waste enormous effort pitching into buyers who have already allocated their budget to other projects. The vendors who understand it run two motions: in-cycle closing plays for active projects, and long-horizon relationship and content plays for the next capital planning cycle.

EHR integration reality is the second major constraint. Epic and Oracle Cerner dominate large health systems; Meditech and Athena own significant mid-market share; dozens of specialty EHRs cover ambulatory, long-term care, and behavioural health. Every health tech deal eventually hits the question: how does this integrate? The honest answer is usually more complicated than the pitch deck implies. Vendors who pre-document integration reality — which EHRs, which modules, HL7 versus FHIR, read-only versus bidirectional — qualify in and out faster and kill fewer deals in late-stage IT review.

Clinical validation is the third. Physicians do not trust vendor claims without evidence, and the evidence that matters is peer-reviewed research, outcome studies, and stories from comparable institutions. A health tech vendor that can point to published clinical outcomes from a recognised health system has a defensible asset that compounds. A vendor that cannot is stuck in proof-of-value pilots that never convert. Content strategy in healthcare is partly a research strategy — the long-term winners publish.

Where healthcare tech GTM breaks

Messaging built for administrators, ignored by clinicians. Most health tech vendors we meet have websites and sequences written in administrative language — ROI, workflow efficiency, cost savings. That language loses the clinical stakeholders whose approval is mandatory. Clinicians want outcomes, evidence, and workflow fit described in clinical terms. The fix is building parallel messaging tracks and ensuring the clinical version is written by someone who understands clinical practice.

Under-qualified pipeline clogging the forecast. Health tech reps routinely fill the pipeline with early-stage conversations that will never close because integration, compliance, or budget reality was not surfaced at qualification. The deal lives in the forecast for six to nine months and then dies. The fix is aggressive qualification on integration, EHR environment, budget timing, and committee size at the first meeting — not at month four.

Pilot purgatory. Health systems love pilots because pilots feel like low-commitment learning. Vendors hate them because many pilots never convert to production. The pilots that do convert were scoped with expansion criteria, executive sponsor buy-in, and a clear path to capital budgeting from day one. The pilots that do not convert were designed to prove the product, not to close a deal.

Generic SDR scripts that clinical stakeholders ignore. A CMIO opening an outbound email from an SDR who calls them "hi there" and asks for 15 minutes is an immediate delete. Clinical and executive healthcare buyers expect specificity, credibility, and brevity. Vendors who cannot staff SDRs with healthcare fluency see meeting rates a fraction of what is achievable.

Missing the capital planning window. By the time a vendor runs a successful pilot and wins champion support, the capital planning cycle has already closed for the year. The deal slips to the next fiscal year, the champion moves roles, priorities shift, and the opportunity evaporates. GTM has to run against the capital planning calendar, not against a traditional sales forecast.

Who we sell to inside healthcare organisations

Healthcare tech is multi-threaded from day one. We build parallel outreach into each of these stakeholders rather than hoping to find a single decision-maker:

  • CMIO / CNIO (Chief Medical or Nursing Informatics Officer). The clinical-technology bridge. Usually the most important stakeholder for any clinical-facing product. Cares about clinical outcomes, physician workflow, EHR integration fit, and evidence from peer institutions. Rarely reachable through generic outbound — requires relationship and credibility-led touches.
  • CIO / CTO / VP Clinical Systems. Owns the technology decision and the integration reality. Cares about EHR compatibility, security, deployment burden, and the total cost to implement (which is usually higher than the licence fee). The stakeholder most likely to kill a deal in late-stage review.
  • VP Clinical Operations / COO. The operational owner for products that change clinical workflow at scale. Cares about throughput, staffing, quality metrics, and patient experience. Often the champion for workflow tools, care coordination, and operational optimisation products.
  • Physician champions and department chairs. Not a formal decision-maker but often the most important political actor inside a deal. A supportive cardiology chair can drag a reluctant IT team forward; an opposing one can kill any clinical product. We build content and evidence that champions can use internally.
  • CFO / VP Revenue Cycle. Owns the financial side of every purchase, and the primary buyer for revenue cycle, claims, and financial workflow tools. Cares about payback, collection rates, and operating margin impact.
  • Procurement, compliance, and BAA review. The gatekeeper layer. Every health tech deal dies or lives through this review.

What we build for healthcare tech companies

Healthcare engagements start with a buyer and committee audit, because most health tech GTM talks to the wrong persona. We map the committee for your specific product, rebuild messaging for each stakeholder, and then layer the channel work on top.

SDR agency and outsourced SDR for healthcare. Dedicated SDRs working a tight named-account list of health systems, hospital groups, or payers. We multi-thread from the first touch across CMIO, CIO, VP Clinical Ops, and physician champions rather than waiting to discover the committee mid-deal. Sequences are anchored to capital planning cycles, EHR transitions, and clinical programme launches — the real buying triggers in this market.

Cold email agency and outbound sales agency infrastructure. Healthcare outbound is a craft not a volume game. We build the deliverability, sending, and sequence infrastructure to survive healthcare's aggressive email security, and we write sequences that CMIOs will actually read — short, specific, evidence-led, and free of the generic language that healthcare buyers filter on reflex.

SEO and clinical evidence content. Healthcare SEO rewards evidence-based, long-form content more than listicles. We build topic authority around clinical problems, outcome studies, and EHR-specific integration guides. We also help structure case studies and published evidence into citable formats that physicians share inside clinical review committees — the single most leverage-heavy content work in health tech.

GEO (generative engine optimisation). Clinical leaders increasingly use LLMs for early research. GEO gets your content cited when a CMIO asks ChatGPT about clinical decision support or revenue cycle modernisation. This channel is early but high-value for health tech because LLMs heavily weight peer-reviewed and authoritative sources, which health tech vendors are naturally positioned to produce.

Demand generation agency and clinical content distribution. Webinars with credible clinical voices, conference and society-journal distribution, capital-planning-cycle nurture campaigns, and physician-champion enablement. Paid media has a modest role in health tech — clinicians rarely click ads — but content distribution through clinical channels consistently works.

Fractional VP of Sales. For Series A and B health tech startups that need senior sales leadership to build the first repeatable enterprise motion, navigate health-system procurement and BAA cycles, and hand off to a full-time CRO once ARR justifies it. Healthcare is not a category where enterprise selling can be learned on the job.

Compliance and procurement enablement. We build or rebuild the trust centre, BAA template, HIPAA posture document, EHR integration matrix, and security package that champions hand to IT and compliance in week one of a deal. Pre-staging these assets consistently shortens healthcare deals more than any other single intervention.

Healthcare GTM work in practice

We've built GTM systems for technology companies selling into regulated, committee-driven markets where patience and precision matter more than volume. Explore our case studies to see how we approach long-cycle, multi-stakeholder deals in healthcare and other complex industries.

Healthcare tech GTM FAQs

What makes healthcare tech GTM different from generic B2B GTM?
Healthcare tech has three structural differences that define the motion. First, buying cycles are the longest in B2B — 12 to 18 months is normal for mid-market health systems, and 18 to 24 months is common for enterprise hospital groups. Second, the buying committee includes clinical stakeholders (CMIO, VP Clinical Ops, physician champions) whose approval logic is entirely different from administrative or IT approval. Clinicians care about patient outcomes, workflow fit, and evidence from peer institutions, not software feature lists. Third, HIPAA, the 21st Century Cures Act, and EHR integration reality mean every deal has a compliance and technical review that cannot be rushed. Treating healthcare tech like generic SaaS is how vendors burn three years of runway chasing deals that never close.
How do you actually sell to hospitals and health systems without getting stuck?
By mapping the buying committee before the first meeting and running a multi-year relationship, not a six-month sales cycle. Health systems buy on fiscal-year calendars tied to capital planning, and the purchase you want this year was budgeted last year. That means GTM has to run on two tracks: in-cycle deals where a committed project exists, and long-horizon relationship building for deals that will land in 12 to 24 months. We build account plans that reflect this reality, multi-thread across CMIO, CIO, VP Clinical Ops, physician champions, and procurement from the first quarter, and pair the sales motion with evidence-based content that clinical buyers trust. Our outbound sales agency and fractional VP of sales services are built around this.
How do you run HIPAA-compliant outbound and demand generation?
HIPAA governs the handling of Protected Health Information, not prospect data for marketing. Standard outbound and demand generation to healthcare professionals — using publicly available titles, work emails, and firmographic data — does not touch HIPAA at all. Where HIPAA does hit GTM is in content and product-marketing workflows that involve patient data, case studies with patient information, or any integration demo. We help health tech vendors structure case studies with proper de-identification, handle customer evidence without exposing PHI, and set up CRM and marketing automation workflows that keep the compliance posture clean. The bigger compliance concern in health tech GTM is actually the customer's procurement process — every hospital has a vendor risk assessment and BAA (Business Associate Agreement) review, which we help vendors pre-stage.
How long are healthcare tech sales cycles really, and why?
Mid-market health systems run 9 to 15 months. Large hospital groups and IDNs run 15 to 24 months, sometimes longer for enterprise-wide clinical software. The length is driven by committee size (often 8 to 15 stakeholders), capital budgeting cycles that lock investment decisions a year ahead, clinical validation steps (pilot studies, physician review boards, workflow assessments), EHR integration planning (Epic, Cerner/Oracle, Meditech, Athena), and security and BAA review. Payer sales are similar — 12 to 18 months is typical. GTM engagements in health tech have to be designed for this reality; anything priced as a 90-day pipeline sprint is selling into the wrong buyer segment.
How do you multi-thread across clinical, IT, and administrative stakeholders?
Different content, different messaging, different sequences for each role — run in parallel. Clinical stakeholders (CMIO, CNIO, VP Clinical Ops, department chairs) respond to peer-reviewed evidence, workflow fit, and stories from comparable institutions. IT stakeholders (CIO, CTO, Head of Clinical Systems) respond to integration depth, security, and EHR compatibility. Administrative stakeholders (CFO, COO, VP Revenue Cycle) respond to ROI, operational metrics, and payback windows. We build three parallel tracks of outbound, content, and enablement — one for each audience — and connect them inside a single account plan so the champion can use our materials to win internal consensus. Our SDR agency and demand generation agency services run this way by default for healthcare clients.
How do you handle EHR integration conversations without over-promising?
Integration is the single most common reason health tech deals die late. A vendor claims Epic or Cerner integration, a hospital IT team investigates, and the reality turns out to be a read-only API that does not meet clinical workflow needs. We help health tech companies document their integration reality honestly — which EHRs, which modules, which HL7 or FHIR interfaces, which deployment patterns work, which do not — and then use that document to qualify in or out at the top of the funnel. Over-qualified leads that understand the integration reality convert at a higher rate than under-qualified leads that die in IT review six months in. Honesty compounds; exaggeration does not.
What role does clinical evidence and published research play in health tech GTM?
An enormous role, and it is underused by most early-stage health tech vendors. Clinical buyers — especially physician champions and CMIOs — make purchase decisions partly on evidence they can defend internally. A peer-reviewed publication, a white paper with a reputable health system, a quantified outcome study, or a conference presentation carries more weight than any product demo. We help health tech vendors structure their customer evidence into citable formats, publish case studies with outcome data (carefully, with patient privacy protected), and build content that physicians can share in clinical review committees. This is the single biggest leverage point we see in health tech content strategy and one of the most defensible assets a health tech company can build.
Do you work with companies selling into hospitals, payers, or pharma?
Primarily health tech vendors selling into hospitals, health systems, payers, and value-based care organisations. We have less experience with pharma-facing GTM (the pharma buyer is structurally different — medical affairs, commercial ops, and regulatory all play different roles than in provider GTM), and we do not take on pure consumer health or DTC work. Within provider and payer tech, we work across clinical software, workflow tools, revenue cycle, interoperability, patient engagement, population health, telehealth, and clinical decision support.
How do you find the right buyer at a hospital when org charts are opaque?
Hospitals and health systems have some of the least-public organisational structures in B2B. The CMIO who owns your decision may not appear on LinkedIn with a clean title, physician champions rarely have "champion" in their job description, and the VP Clinical Operations at one system sits under the COO while at another it sits under the CMO. We invest in manual account mapping at the top of the funnel — using directory research, conference attendee lists, publication databases, and LinkedIn graph search — rather than relying on generic data providers that miss clinical roles entirely. The upfront cost is higher but the outbound conversion rate is roughly double what vendors get with a generic list pull.
What does a healthcare tech GTM engagement with UpliftGTM look like?
Positioning and buyer audit first, because health tech messaging routinely talks to the wrong stakeholder. Then a combination of outbound, SEO, demand generation, and enablement scoped to the stage of your company and the shape of your buyer. Engagements run 9 to 18 months because health tech cycles demand patience — we will not take on an engagement with a three-month horizon because the work cannot pay back on that timeline. Reporting is tied to qualified pipeline, sales-accepted opportunities, and pilot conversions — not MQLs, which are a near-meaningless metric in health tech. You own the entire GTM system, including the trust and compliance enablement assets, when we hand off.

Build a GTM system your health tech company can scale on

30-minute working session with Jamie. We'll pressure-test your buyer committee map, outbound, and compliance readiness, and leave you with a plan — whether or not we work together.